Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epoetin theta 2,000units/0.5ml inj pre-filled syringes
0901030S0AAABAB
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 20,000units/1ml inj pre-filled syringes
0901030S0AAAGAG
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 3,000units/0.5ml inj pre-filled syringes
0901030S0AAACAC
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 30,000units/1ml inj pre-filled syringes
0901030S0AAAHAH
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 4,000units/0.5ml inj pre-filled syringes
0901030S0AAADAD
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 5,000units/0.5ml inj pre-filled syringes
0901030S0AAAEAE
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin zeta 1,000units/0.3ml inj pre-filled syringes
0901030Q0AAAAAA
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 10,000units/1ml inj pre-filled syringes
0901030Q0AAAHAH
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 2,000units/0.6ml inj pre-filled syringes
0901030Q0AAABAB
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 20,000units/0.5ml inj pre-filled syringes
0901030Q0AAAJAJ
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 3,000units/0.9ml inj pre-filled syringes
0901030Q0AAACAC
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 40,000units/1ml inj pre-filled syringes
0901030Q0AAAIAI
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 5,000units/0.5ml inj pre-filled syringes
0901030Q0AAAEAE
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Eporatio 1,000units/0.5ml inj pre-filled syringes
0901030S0BBAAAA
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 10,000units/1ml inj pre-filled syringes
0901030S0BBAFAF
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 2,000units/0.5ml inj pre-filled syringes
0901030S0BBABAB
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 20,000units/1ml inj pre-filled syringes
0901030S0BBAGAG
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 3,000units/0.5ml inj pre-filled syringes
0901030S0BBACAC
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 30,000units/1ml inj pre-filled syringes
0901030S0BBAHAH
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 4,000units/0.5ml inj pre-filled syringes
0901030S0BBADAD
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 5,000units/0.5ml inj pre-filled syringes
0901030S0BBAEAE
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eprex 1,000units/0.5ml inj pre-filled syringes
0901030D0BBAHAH
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 40,000units/1ml solution for injection vials
0901030D0BBASAS
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 7,000units/0.7ml inj pre-filled syringes
0901030D0BBAPAP
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 9,000units/0.9ml inj pre-filled syringes
0901030D0BBARAR
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.